Form 4: Arteris CEO Sells 50,000 Shares Under 10b5-1 Plan

Arteris, Inc. President and CEO, K. Charles Janac, sold 50,000 shares of common stock for a weighted average price of $13.0742 per share under a pre-arranged 10b5-1 trading plan.

Summary

• K. Charles Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported the sale of 50,000 shares of common stock.
• The transaction occurred on October 8, 2025, at a weighted average price of $13.0742 per share.
• The shares were sold in multiple transactions at prices ranging from $13.00 to $13.20.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Janac on March 5, 2025.
• Following the transaction, Mr. Janac directly owns 161,759 shares of common stock.
• He also indirectly beneficially owns 9,689,071 shares through Bayview Legacy, LLC, where he is the manager, and 56,252 shares through the Charles and Lydia Janac Trust, where he serves as trustee.

Sentiment

Score: 5

Explanation: The transaction is a pre-planned sale under a 10b5-1 plan, which typically indicates a routine liquidity event rather than a change in management's outlook on the company. While it represents a reduction in insider ownership, the pre-arranged nature mitigates a strong negative interpretation.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

This filing is a routine disclosure of an insider transaction and does not provide information related to broader industry trends or competitors.

Related Party Transactions

• K. Charles Janac indirectly beneficially owns shares through Bayview Legacy, LLC, where he serves as manager.
• K. Charles Janac indirectly beneficially owns shares through the Charles and Lydia Janac Trust, for which he serves as trustee.

Stakeholder Impact

• Shareholders may note a reduction in direct insider ownership by the CEO, although the sale was pre-planned under a 10b5-1 plan.

Key Dates

Recommendation

The sale of shares by the CEO, K. Charles Janac, was conducted under a pre-arranged 10b5-1 trading plan. Such plans are typically established for personal financial planning and liquidity, rather than signaling a change in the company's fundamental prospects. While it represents a decrease in direct insider holdings, the pre-planned nature suggests it is a routine event. Without additional information regarding company performance, strategic shifts, or broader market conditions, this single transaction does not warrant a change from a 'hold' recommendation.

Keywords

Arteris, AIP, insider trading, Form 4, stock sale, CEO, 10b5-1 plan